Altasciences
Laval, QC (HQ); Kansas City, MO; Seattle, WA; multiple North American sites · United States
Specialization: Early phase drug development, preclinical safety, clinical pharmacology (Phase I-II), bioanalysis, formulation/manufacturing
Key Differentiator
UNIQUE hybrid CRO+CDMO model spanning preclinical → Phase IIa
Core Services
Preclinical through Phase IIa (integrated); Bioanalytical; PK/PD; Abuse liability; Clinical pharmacology; GLP toxicology; Formulation development; Manufacturing
Capabilities
Market Intelligence
UNIQUE hybrid CRO+CDMO model spanning preclinical → Phase IIa. Canadian-headquartered with strong US presence. Seamless early development partner.
Website
https://www.altasciences.comSimilar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.